Literature DB >> 1461091

In vivo NMR T2 relaxation of experimental brain tumors in the cat: a multiparameter tissue characterization.

M Hoehn-Berlage1, T Tolxdorff, K Bockhorst, Y Okada, R I Ernestus.   

Abstract

Experimental gliomas (F98) were inoculated in cat brain for the systematic study of their in vivo T2 relaxation time behavior. With a CPMG multi-echo imaging sequence, a train of 16 echoes was evaluated to obtain the transverse relaxation time and the magnetization M(0) at time t = 0. The magnetization decay curves were analyzed for biexponentiality. All tissues showed monoexponential T2, only that of the ventricular fluid and part of the vital tumor tissue were biexponential. Based on these NMR relaxation parameters the tissues were characterized, their correct assignment being assured by comparison with histological slices. T2 of normal grey and white matter was 74 +/- 6 and 72 +/- 6 msec, respectively. These two tissue types were distinguished through M(0) which for white matter was only 0.88 of the intensity of grey matter in full agreement with water content, determined from tissue specimens. At the time of maximal tumor growth and edema spread a tissue differentiation was possible in NMR relaxation parameter images. Separation of the three tissue groups of normal tissue, tumor and edema was based on T2 with T2(normal) < T2(tumor) < T2(edema). Using M(0) as a second parameter the differentiation was supported, in particular between white matter and tumor or edema. Animals were studied at 1-4 wk after tumor implantation to study tumor development. The magnetization M(0) of both tumor and peritumoral edema went through a maximum between the second and third week of tumor growth. T2 of edema was maximal at the same time with 133 +/- 4 msec, while the relaxation time of tumor continued to increase during the whole growth period, reaching values of 114 +/- 12 msec at the fourth week. Thus, a complete characterization of pathological tissues with NMR relaxometry must include a detailed study of the developmental changes of these tissues to assure correct experimental conditions for the goal of optimal contrast between normal and pathological regions in the NMR images.

Entities:  

Mesh:

Year:  1992        PMID: 1461091     DOI: 10.1016/0730-725x(92)90448-9

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  8 in total

1.  Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival.

Authors:  Elke Hattingen; Alina Jurcoane; Keivan Daneshvar; Ulrich Pilatus; Michel Mittelbronn; Joachim P Steinbach; Oliver Bähr
Journal:  Neuro Oncol       Date:  2013-08-07       Impact factor: 12.300

2.  Quantification of Nonenhancing Tumor Burden in Gliomas Using Effective T2 Maps Derived from Dual-Echo Turbo Spin-Echo MRI.

Authors:  Benjamin M Ellingson; Albert Lai; Huytram N Nguyen; Phioanh L Nghiemphu; Whitney B Pope; Timothy F Cloughesy
Journal:  Clin Cancer Res       Date:  2015-04-21       Impact factor: 12.531

Review 3.  Radiogenomics and imaging phenotypes in glioblastoma: novel observations and correlation with molecular characteristics.

Authors:  Benjamin M Ellingson
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

4.  Diffusion-weighted MRI for monitoring tumor response to photodynamic therapy.

Authors:  Hesheng Wang; Baowei Fei
Journal:  J Magn Reson Imaging       Date:  2010-08       Impact factor: 4.813

5.  Comparison of T2 and LASER T2dagger image contrast in a rat model of acute cerebral ischemia.

Authors:  Simona Nikolova; Ziqi Sun; Miranda Bellyou; Robert Bartha
Journal:  Magn Reson Imaging       Date:  2007-12-03       Impact factor: 2.546

6.  Characterization of brain tumours with spin-spin relaxation: pilot case study reveals unique T 2 distribution profiles of glioblastoma, oligodendroglioma and meningioma.

Authors:  Cornelia Laule; Thorarin A Bjarnason; Irene M Vavasour; Anthony L Traboulsee; G R Wayne Moore; David K B Li; Alex L MacKay
Journal:  J Neurol       Date:  2017-09-11       Impact factor: 4.849

7.  Quantitative T1 and T2 mapping in recurrent glioblastomas under bevacizumab: earlier detection of tumor progression compared to conventional MRI.

Authors:  Stephanie Lescher; Alina Jurcoane; Andreas Veit; Oliver Bähr; Ralf Deichmann; Elke Hattingen
Journal:  Neuroradiology       Date:  2014-10-07       Impact factor: 2.804

8.  T2 mapping of the peritumoral infiltration zone of glioblastoma and anaplastic astrocytoma.

Authors:  Timo Alexander Auer; Maike Kern; Uli Fehrenbach; Yasemin Tanyldizi; Martin Misch; Edzard Wiener
Journal:  Neuroradiol J       Date:  2021-02-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.